• Return to Headlines

Shares of Becton Dickinson Has Risen Above Previous 52-Week High

By Nick Russo

Becton Dickinson (NYSE:BDX) traded today at a new 52-week high of $202.00. This new high was reached on below average trading volume as 95,000 shares traded hands, while the average 30-day volume is approximately 885,000 shares.

In the past 52 weeks, shares of Becton Dickinson have traded between a low of $161.29 and a high of $202.00 and are now at $201.55, which is 25% above that low price. Over the last five market days, the 200-day moving average (MA) has gone up 0.2% while the 50-day MA has advanced 0.8%.

Becton Dickinson (NYSE:BDX) is currently priced 0.1% above its average consensus analyst price target of $201.31. The stock should find initial support at its 50-day moving average (MA) of $153.96 and further support at its 200-day MA of $147.03.

Becton, Dickinson and Company is a global medical technology company engaged principally in the development, manufacture, and sale of medical devices, instrument systems, and reagents used by healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry, and the general public.

SmarTrend recommended that subscribers consider buying shares of Becton Dickinson on January 10th, 2017 as our proprietary SmarTrend analytics indicated a new Uptrend was in progress when shares hit $170.63. Since that recommendation, shares of Becton Dickinson have risen 17.8%. We continue to monitor BDX for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.

Keywords: 52 week high/lows becton dickinson

Ticker(s): BDX